TerrAscend (OTCMKTS:TSNDF) & GE HealthCare Technologies (NASDAQ:GEHC) Head-To-Head Survey

TerrAscend (OTCMKTS:TSNDF) and GE HealthCare Technologies (NASDAQ:GEHC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Analyst Ratings

This is a summary of current ratings and price targets for TerrAscend and GE HealthCare Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	1	0	0	2.00
GE HealthCare Technologies	0	11	12	0	2.52

GE HealthCare Technologies has a consensus price target of $82.17, indicating a potential downside of 1.02%. Given GE HealthCare Technologies’ stronger consensus rating and higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than TerrAscend.

Valuation & Earnings

This table compares TerrAscend and GE HealthCare Technologies”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TerrAscend	$260.56 million	0.45	-$81.33 million	($0.09)	-4.21
GE HealthCare Technologies	$20.62 billion	1.82	$2.08 billion	$4.74	17.51

GE HealthCare Technologies has higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

TerrAscend has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500.

Institutional and Insider Ownership

5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 31.9% of TerrAscend shares are owned by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares TerrAscend and GE HealthCare Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-28.96%	-30.76%	-4.89%
GE HealthCare Technologies	9.96%	20.45%	5.97%

Summary

GE HealthCare Technologies beats TerrAscend on 12 of the 14 factors compared between the two stocks.

About TerrAscend

TerrAscend is a cannabis company that cultivates, processes and sells cannabis products through retail and wholesale channels. Its offerings include cannabis flower, pre-rolls, concentrates, edibles and other consumer products, sold under a portfolio of company and partner brands. The company operates in several U.S. markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail business includes dispensaries operating under names such as The Apothecarium and Gage, alongside cultivation and processing facilities that supply its stores and other retailers.

About GE HealthCare Technologies

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.